What are the medications used to treat anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Anaphylaxis Management

Epinephrine is the first-line and most critical medication for anaphylaxis treatment, and should be administered promptly via intramuscular injection in the mid-outer thigh at a dose of 0.01 mg/kg (maximum 0.5 mg) before any other interventions. 1

Primary Treatment: Epinephrine

Mechanism and Benefits

  • Acts on both alpha and beta-adrenergic receptors 2:
    • α1 effects: Increases vasoconstriction, peripheral vascular resistance, and decreases mucosal edema
    • β1 effects: Increases inotropy (heart contractility) and chronotropy (heart rate)
    • β2 effects: Causes bronchodilation and decreases inflammatory mediator release from mast cells and basophils

Administration

  • Route: Intramuscular injection in the lateral thigh (preferred site) 3, 1
  • Dose: 0.01 mg/kg (maximum 0.5 mg) 1
  • Autoinjector dosing:
    • 0.15 mg for patients 10-25 kg
    • 0.3 mg for patients >25 kg 1
  • May repeat every 5-15 minutes if symptoms persist 3

Critical Importance

  • Delayed epinephrine administration is associated with increased mortality and poor outcomes 3, 1
  • No absolute contraindications to epinephrine in anaphylaxis, even with cardiac disease 1

Second-Line/Adjunctive Medications

Antihistamines

  • H1 Antagonists (e.g., Diphenhydramine)

    • Dose: 1-2 mg/kg or 25-50 mg IV/IM/oral 3, 1
    • Role: Helps with cutaneous symptoms (urticaria, pruritus, flushing) only
    • Limitation: Does not treat respiratory or cardiovascular symptoms 3
  • H2 Antagonists (e.g., Ranitidine)

    • Dose: 1 mg/kg or 50 mg IV 3, 1
    • Note: Combination of H1 and H2 antagonists is superior to H1 alone 3

Corticosteroids

  • Methylprednisolone: 1-2 mg/kg/day IV every 6 hours 3, 1
  • Prednisone: 0.5 mg/kg orally for less severe episodes 3
  • Role: May help prevent protracted or biphasic reactions
  • Limitation: No proven role in acute management; slow onset of action 3, 1

Bronchodilators

  • Albuterol: 2.5-5 mg in 3 mL saline via nebulizer 3
  • Role: For bronchospasm resistant to epinephrine 3

Vasopressors (for refractory hypotension)

  • Dopamine: 400 mg in 500 mL D5W, administered at 2-20 μg/kg/min 3
  • Requires continuous hemodynamic monitoring 3

Special Situations

  • For patients on β-blockers with refractory symptoms:
    • Glucagon: 1-5 mg IV over 5 minutes, followed by infusion (5-15 μg/min) 3
    • Caution: May cause nausea and vomiting 3

Medication Sequence and Priorities

  1. First: Epinephrine IM in lateral thigh
  2. Second: Fluid resuscitation if hypotensive (20 mL/kg normal saline) 1
  3. Third: Antihistamines for cutaneous symptoms
  4. Fourth: Corticosteroids if history of severe reactions or asthma
  5. Fifth: Bronchodilators if persistent bronchospasm
  6. Sixth: Additional vasopressors if refractory hypotension

Common Pitfalls to Avoid

  • Never delay epinephrine administration to administer antihistamines or corticosteroids first 3, 1
  • Never use antihistamines alone as primary treatment for anaphylaxis 3
  • Never administer epinephrine intravenously except in cardiac arrest or profound hypotension unresponsive to IM epinephrine and fluid resuscitation 3, 1
  • Never discharge patients too early - observe for at least 4-6 hours after symptom resolution due to risk of biphasic reactions 1
  • Never withhold epinephrine due to concerns about cardiac disease - benefits outweigh risks in anaphylaxis 1

Follow-up Medications

  • Prescribe epinephrine autoinjectors upon discharge 1
  • Consider 3-5 day course of oral antihistamines and corticosteroids for patients with severe reactions 1

Anaphylaxis is a potentially life-threatening condition requiring immediate recognition and treatment. While multiple medications play a role in management, epinephrine remains the cornerstone of therapy and should never be delayed or substituted.

References

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.